证券记录 · 已归档季度
AXSM
Axsome Therapeutics, Inc. · Healthcare · Biotechnology
17被追踪持有人
-1Δ持有人
13.98M持有股份
$1.46B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.6% ·
股份流向 +6.2% ·
净新建仓位 -5.9%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +8 | 27.61M | $6.75B | +16 | −7 |
| Q1 2026 | 125 | +4 | 27.78M | $4.69B | +9 | −6 |
| Q4 2025 | 120 | +1 | 28.15M | $5.13B | +2 | — |
| Q3 2025 | 19 | 0 | 15.93M | $1.93B | +1 | −2 |
| Q2 2025 | 17 | -1 | 13.98M | $1.46B | — | −1 |
| Q1 2025 | 15 | +3 | 4.41M | $513.88M | +3 | — |
| Q4 2024 | 12 | +1 | 3.90M | $329.80M | +1 | — |
| Q3 2024 | 10 | 0 | 3.50M | $314.34M | — | — |
| Q2 2024 | 10 | — | 4.77M | $384.18M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 3.95M | — | $411.82M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 3.95M | — | $411.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 3.95M | — | $411.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 3.95M | — | $411.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 3.95M | — | $411.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 3.83M | — | $400.33M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Geode Capital Management ✦ (被动) | 989.45K | +5.8% | $103.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 989.45K | +5.8% | $103.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 976.73K | — | $101.96M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 976.73K | — | $101.96M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 976.73K | — | $101.96M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 976.73K | — | $101.96M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (被动) | 958.50K | +5.8% | $100.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 725.04K | +3.1% | $75.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 612.74K | +1816.2% | $63.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 612.74K | +1816.2% | $63.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Norges Bank ✦ (被动) | 468.33K | +7.0% | $48.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Adage Capital Partners ✦ | 447.00K | +831.2% | $46.66M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 41 | Point72 Asset Management ✦ | 350.97K | +178.1% | $36.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 42 | D. E. Shaw & Co. ✦ | 200.76K | -63.3% | $20.96M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 200.76K | -63.3% | $20.96M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 138.70K | +3.2% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 127.82K | +119.0% | $13.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 127.82K | +119.0% | $13.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 127.82K | +119.0% | $13.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 127.82K | +119.0% | $13.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 127.82K | +119.0% | $13.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | Bridgewater Associates ✦ | 107.29K | +150.5% | $11.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 51 | Marshall Wace ✦ | 56.72K | -17.4% | $5.92M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 52 | Marshall Wace ✦ | 56.72K | -17.4% | $5.92M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 53 | Millennium Management ✦ | 30.62K | -87.0% | $3.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 54 | Citadel Advisors ✦ | 13.62K | -83.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Two Sigma Investments | $5.48M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 11.40K 股份, $1,926 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据